Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer mortality, despite significant improvements in diagnostic imaging and operative mortality rates. The 5-year survival rate remains less than 5% because of microscopic or gross metastatic disease at time of diagnosis. The Cl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Philip, Philip A., Mooney, Margaret, Jaffe, Deborah, Eckhardt, Gail, Moore, Malcolm, Meropol, Neal, Emens, Leisha, O'Reilly, Eileen, Korc, Murray, Ellis, Lee, Benedetti, Jacqueline, Rothenberg, Mace, Willett, Christopher, Tempero, Margaret, Lowy, Andrew, Abbruzzese, James, Simeone, Diane, Hingorani, Sunil, Berlin, Jordan, Tepper, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7587401/
https://ncbi.nlm.nih.gov/pubmed/19858397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.9022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados